Estimation of coagulation-fibrinolytic factors in DIC

Bibliotheca Haematologica
|January 1, 1983
PubMed

Insights

Disseminated intravascular coagulation (DIC) diagnosis relies on fibrinogen (Fbg), fibrin degradation products (FDP), and antithrombin III (AT III) tests. Rapid diagnostic methods like thromboelastography (TEG) are crucial for timely DIC management.

Area of Science:

  • Hematology
  • Clinical Pathology

Background:

  • Disseminated intravascular coagulation (DIC) is a complex hematological disorder.
  • Accurate and timely diagnosis of DIC is critical for effective patient management.
  • Existing diagnostic methods require refinement for improved sensitivity and speed.

Purpose of the Study:

  • To analyze coagulation laboratory records for patients with presumptive DIC.
  • To identify key diagnostic markers and evaluate novel diagnostic approaches for DIC.
  • To assess the effectiveness of heparin therapy in DIC patients.

Main Methods:

  • Computer analysis of 553 coagulation laboratory records from 1979-1981.
  • Evaluation of diagnostic tests including fibrinogen (Fbg), fibrin degradation products (FDP), and antithrombin III (AT III).
  • Analysis of SDS-PAGE patterns of Fbg and immunoprecipitation of AT III.
  • Assessment of thromboelastography (TEG) for detecting procoagulant activity.
  • Monitoring of activated partial thromboplastin time (APTT), heparin levels, and fibrin peptide A (FPA) during heparin therapy.

Main Results:

  • Fibrinogen (Fbg), fibrin degradation products (FDP), and antithrombin III (AT III) were identified as key diagnostic markers for DIC.
  • DIC can occur with normal or elevated Fbg levels, necessitating sequential testing.
  • SDS-PAGE revealed reduced low-molecular-weight Fbg and suggested high-affinity thrombin binding to high-molecular-weight Fbg in DIC.
  • Changes in AT III immunoprecipitation patterns may indicate serine protease binding.
  • Thromboelastography (TEG) demonstrated potential as a rapid diagnostic test for DIC.
  • Heparin's anticoagulant effect was monitored by APTT and heparin levels; its antithrombotic effect was assessed by FPA (immediate) and Fbg, FDP, AT III (delayed).

Conclusions:

  • Sequential laboratory testing is essential for accurate DIC assessment.
  • Thromboelastography (TEG) offers a rapid and useful diagnostic method for DIC.
  • Clinical demand exists for faster and simpler DIC diagnostic tests.
  • Heparin therapy monitoring requires distinct markers for anticoagulant and antithrombotic effects.